Shanghai Aucta Pharmaceuticals Co., Ltd.
USPTO PatentsView assignee record - 6 granted patents across 4 technology areas, recorded in grant years 2020–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).
The verdict
According to USPTO PatentsView, Shanghai ranks #42,927 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 4 technology areas.
- #42,927
- of 49,997 US assignees by volume
- Top 22%
- by Innovation Score (45.8/100)
- 20.0
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R42927 · Foreign Corporation #42,927 · 6 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 6 grants
- LOWER-Q #42,927/49,997
- PHOTO-FINISH Seven Dreamers…
- CPC-NARROW A61K · 4 areas
- INNOV-PAR 45.8/100
- CLAIMS-DENSE 20.0 claims/avg
- TYPE-FRNCORP Foreign Corp
- SPAN-YRS 2020–2024 · 5y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Seven Dreamers Laboratories, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Shanghai’s 45.8 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Shanghai
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Automated Assembly · near
Automated Assembly · near
46 score
- Parsons Xtreme Golf · near
Parsons Xtreme Golf · near
46 score
- Shanghai Aucta… · this assignee
Shanghai Aucta… · this assignee
46 score
- Ingenico · near
Ingenico · near
46 score
- Phosphorus Free… · near
Phosphorus Free… · near
46 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Shanghai's Innovation Score is 45.8/100 (top 22% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Shanghai?
Each dot is one of Shanghai’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Shanghai’s own 20.0 claims/patent is ABOVE the 7.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Shanghai's grants concentrate
Shanghai Aucta Pharmaceuticals Co., Ltd. is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2022 (2 grants) versus a trough of 1 in 2020. By volume, Shanghai sits between Seven Dreamers Laboratories, Inc. and Shanghai NanoJClean Technology Co., Ltd..
Shanghai's three-year grant acceleration
Shanghai Aucta Pharmaceuticals Co., Ltd. shows 5 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Shanghai's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Seven Dreamers La…
Seven Dreamers Laboratories, Inc.
6 patents
- Shale Oil Tools
Shale Oil Tools, LLC
6 patents
- Shandong Haoxin M…
Shandong Haoxin Machinery Co., Ltd.
6 patents
- Shanghai Allist P…
Shanghai Allist Pharmaceuticals Co., Ltd.
6 patents
- Shanghai Benxu Pr…
Shanghai Benxu Precision Mold Co., Ltd.
6 patents
- Shanghai Lumosa T…
Shanghai Lumosa Therapeutics Co., Ltd.
6 patents
- Shanghai Mebania…
Shanghai Mebania Industry Co., Ltd.
6 patents
- Shanghai Nanojcle…
Shanghai NanoJClean Technology Co., Ltd.
6 patents
- Shanghai Aucta Ph… ◀
Shanghai Aucta Pharmaceuticals Co., Ltd.
6 patents
What this shows Shanghai holds 6 patents at rank #43,151, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Shanghai
By rank, the assignees closest to #43,151 in granted patent volume.
- Seven Dreamers Laboratories, Inc. #43,147 · 6 patents
- Shale Oil Tools, LLC #43,148 · 6 patents
- Shandong Haoxin Machinery Co., Ltd. #43,149 · 6 patents
- Shanghai Allist Pharmaceuticals Co., Ltd. #43,150 · 6 patents
- Shanghai Benxu Precision Mold Co., Ltd. #43,152 · 6 patents
- Shanghai Lumosa Therapeutics Co., Ltd. #43,153 · 6 patents
- Shanghai Mebania Industry Co., Ltd. #43,154 · 6 patents
- Shanghai NanoJClean Technology Co., Ltd. #43,155 · 6 patents
Leaders in A61K (Preparations FOR Medical)
Other assignees with the most granted patents in Shanghai's primary technology class.
- The Regents of the University of California 1,779 in class
- L'Oreal 1,250 in class
- Novartis AG 988 in class
- The Procter & Gamble Company 985 in class
- The Board of Regents of the University of Texas System 950 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 813 in class
- The Trustees of the University of Pennsylvania 768 in class
- Merck Sharp & Dohme LLC 760 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Shanghai, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Shanghai ranks #3,449 of 7,163 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (46 here).
Shanghai's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
46 Top 22% higher than 78% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 1 | 16.7% |
| 2022 | 2 | 33.3% |
| 2023 | 1 | 16.7% |
| 2024 | 2 | 33.3% |
Which technologies does Shanghai Aucta Pharmaceuticals Co., Ltd. patent most?
Top 4 of 4 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Shanghai Aucta Pharmaceuticals Co., Ltd.'s patent record in context - here's where to go next.
- Shanghai Aucta Pharmaceuticals Co., Ltd.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
- Ranked #42,927 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Shanghai Aucta Pharmaceuticals Co., Ltd. against Seven Dreamers Laboratories, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 45.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.